Even though its detection may support the hit-and-run hypothesis, it seems like the immune response markers analyzed in this series, such as CD8, cytotoxic T cells, PDL1 and CD68, only are increased when EBERs is expressed in more than 20% of tumor cells, defined as EBV+ DLBCL. This evidence concerns the gene CD8A and diffuse large B-cell lymphoma.